437 related articles for article (PubMed ID: 25810334)
1. Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.
Abdul-Rahim AH; Perez AC; Fulton RL; Jhund PS; Latini R; Tognoni G; Wikstrand J; Kjekshus J; Lip GY; Maggioni AP; Tavazzi L; Lees KR; McMurray JJ; ;
Circulation; 2015 Apr; 131(17):1486-94; discussion 1494. PubMed ID: 25810334
[TBL] [Abstract][Full Text] [Related]
2. Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.".
Abdul-Rahim AH; Perez AC; Fulton RL; Jhund PS; Latini R; Tognoni G; Wikstrand J; Kjekshus J; Lip GY; Maggioni AP; Tavazzi L; Lees KR; McMurray JJ
Circulation; 2015 Dec; 132(22):e358. PubMed ID: 26621661
[No Abstract] [Full Text] [Related]
3. Letter by Lin et al Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.".
Lin GM; Hung Y; Li YH
Circulation; 2015 Dec; 132(22):e357. PubMed ID: 26621660
[No Abstract] [Full Text] [Related]
4. Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.
Dauriz M; Targher G; Temporelli PL; Lucci D; Gonzini L; Nicolosi GL; Marchioli R; Tognoni G; Latini R; Cosmi F; Tavazzi L; Maggioni AP;
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679559
[TBL] [Abstract][Full Text] [Related]
5. QT variability index on 24-hour Holter independently predicts mortality in patients with heart failure: analysis of Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial.
Dobson CP; La Rovere MT; Pinna GD; Goldstein R; Olsen C; Bernardinangeli M; Veniani M; Midi P; Tavazzi L; Haigney M;
Heart Rhythm; 2011 Aug; 8(8):1237-42. PubMed ID: 21457791
[TBL] [Abstract][Full Text] [Related]
6. n-3PUFA and Holter-derived autonomic variables in patients with heart failure: data from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) Holter substudy.
La Rovere MT; Staszewsky L; Barlera S; Maestri R; Mezzani A; Midi P; Marchioli R; Maggioni AP; Tognoni G; Tavazzi L; Latini R;
Heart Rhythm; 2013 Feb; 10(2):226-32. PubMed ID: 23107655
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Cleland JG; McMurray JJ; Kjekshus J; Cornel JH; Dunselman P; Fonseca C; Hjalmarson A; Korewicki J; Lindberg M; Ranjith N; van Veldhuisen DJ; Waagstein F; Wedel H; Wikstrand J;
J Am Coll Cardiol; 2009 Nov; 54(20):1850-9. PubMed ID: 19892235
[TBL] [Abstract][Full Text] [Related]
8. Stroke and anticoagulation in heart failure without atrial fibrillation: from risk to opportunity.
Homma S; Ye S
Circulation; 2015 Apr; 131(17):1465-7. PubMed ID: 25810335
[No Abstract] [Full Text] [Related]
9. Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
Maggioni AP; Fabbri G; Lucci D; Marchioli R; Franzosi MG; Latini R; Nicolosi GL; Porcu M; Cosmi F; Stefanelli S; Tognoni G; Tavazzi L;
Eur Heart J; 2009 Oct; 30(19):2327-36. PubMed ID: 19717850
[TBL] [Abstract][Full Text] [Related]
10. Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide.
Wedel H; McMurray JJ; Lindberg M; Wikstrand J; Cleland JG; Cornel JH; Dunselman P; Hjalmarson A; Kjekshus J; Komajda M; Kuusi T; Vanhaecke J; Waagstein F;
Eur J Heart Fail; 2009 Mar; 11(3):281-91. PubMed ID: 19168876
[TBL] [Abstract][Full Text] [Related]
11. International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
Kristensen SL; Køber L; Jhund PS; Solomon SD; Kjekshus J; McKelvie RS; Zile MR; Granger CB; Wikstrand J; Komajda M; Carson PE; Pfeffer MA; Swedberg K; Wedel H; Yusuf S; McMurray JJ
Circulation; 2015 Jan; 131(1):43-53. PubMed ID: 25406306
[TBL] [Abstract][Full Text] [Related]
12. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L
Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833
[TBL] [Abstract][Full Text] [Related]
13. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.
Gravning J; Askevold ET; Nymo SH; Ueland T; Wikstrand J; McMurray JJ; Aukrust P; Gullestad L; Kjekshus J;
Circ Heart Fail; 2014 Jan; 7(1):96-103. PubMed ID: 24284025
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial.
Mantovani A; Targher G; Temporelli PL; Lucci D; Gonzini L; Nicolosi GL; Marchioli R; Tognoni G; Latini R; Cosmi F; Tavazzi L; Maggioni AP;
Metabolism; 2018 Jun; 83():205-215. PubMed ID: 29477817
[TBL] [Abstract][Full Text] [Related]
15. Fatigue as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Perez-Moreno AC; Jhund PS; Macdonald MR; Petrie MC; Cleland JG; Böhm M; van Veldhuisen DJ; Gullestad L; Wikstrand J; Kjekshus J; Lewsey JD; McMurray JJ
JACC Heart Fail; 2014 Apr; 2(2):187-97. PubMed ID: 24720928
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial.
Røysland R; Masson S; Omland T; Milani V; Bjerre M; Flyvbjerg A; Di Tano G; Misuraca G; Maggioni AP; Tognoni G; Tavazzi L; Latini R;
Am Heart J; 2010 Aug; 160(2):286-93. PubMed ID: 20691834
[TBL] [Abstract][Full Text] [Related]
17. Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial.
Finzi AA; Latini R; Barlera S; Rossi MG; Ruggeri A; Mezzani A; Favero C; Franzosi MG; Serra D; Lucci D; Bianchini F; Bernasconi R; Maggioni AP; Nicolosi G; Porcu M; Tognoni G; Tavazzi L; Marchioli R
Am Heart J; 2011 Feb; 161(2):338-343.e1. PubMed ID: 21315217
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
[TBL] [Abstract][Full Text] [Related]
19. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
Latini R; Gullestad L; Masson S; Nymo SH; Ueland T; Cuccovillo I; Vårdal M; Bottazzi B; Mantovani A; Lucci D; Masuda N; Sudo Y; Wikstrand J; Tognoni G; Aukrust P; Tavazzi L;
Eur J Heart Fail; 2012 Sep; 14(9):992-9. PubMed ID: 22740508
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers and diagnostics in heart failure.
Gaggin HK; Januzzi JL
Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
